Polianta Ltd’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,500
Closed -$920K 81
2023
Q3
$920K Buy
+13,500
New +$1.15M 0.45% 66
2021
Q2
Sell
-8,400
Closed -$1.11M 80
2021
Q1
$1.11M Buy
+8,400
New +$1.15M 0.61% 53
2020
Q1
Sell
-12,800
Closed -$1.18M 69
2019
Q4
$1.18M Buy
+12,800
New +$1.13M 0.72% 22

Other funds holding EXAS

Polianta Ltd's EXAS Position: Q4 2023 in Review

Polianta Ltd sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 13,500 shares — an estimated $920K sold.

Polianta Ltd first reported a position in EXAS in Q4 2019 and held it in 3 quarters. The position peaked at $1.18M in Q4 2019. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Polianta Ltd reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Polianta Ltd sold 13,500 Exact Sciences shares in Q4 2023, an estimated $920K.
  • Polianta Ltd first reported a position in Exact Sciences in Q4 2019 and held it in 3 quarters.
  • Polianta Ltd's Exact Sciences position peaked at $1.18M in Q4 2019.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Polianta Ltd's 13F filing for Q4 2023, filed 9 Jan 2024.